Thats why we ended the partnership. In a post on X, Hims Chief Executive Andrew Dudum called the Novo executives comments misleading. He said Novo had been pressuring Hims to steer patients to Wegovy regardless of whether it was clinically best for patients. We refuse to be strong-armed, he said, adding that Hims will continue to offer a range of treatments, including Wegovy. Hims shares tumbled 35% in New York Monday the most ever as analysts said the withdrawal would leave the telehealth company without an attractive obesity profit stream
They do carry below average profit margins, in part due to their cold storage requirements
doi:10.1016/S0002-9343(98)00300-3 74
The problem is not the dose Sometimes the medication is working exactly as it should, but lifestyle factors are preventing weight loss
Pregnancy and Breastfeeding: You should stop using Semaglutide and Tirzepatide at least two (2) months before you plan to get pregnant and should not use it while breastfeeding
Side effects Potential side effects include nausea, vomiting, diarrhea, headache, fatigue, dizziness, and constipation